Disruptive Pharma AB (publ)

11/04/2026 | Press release | Distributed by Public on 11/04/2026 03:00

Disruptive Pharma strengthens R&D team with Rosita Pettersson Kneiszl

Disruptive Pharma continues to grow its team with the addition of Rosita Pettersson Kneiszl as Formulation Scientist, strengthening our formulation development capabilities as we advance Formulite® and expand our work with pharmaceutical and biotechnology partners.

Rosita is a licensed pharmacist with a PhD in Pharmaceutical Sciences, adding scientific expertise in pharmaceutical research and drug development to our growing team. In her new role, Rosita will contribute to the development and evaluation of formulations using Formulite®, helping to address formulation challenges associated with poorly soluble and other challenging drug compounds.

Formulation development is central to translating the potential of Formulite® into oral drug products. The platform offers opportunities to improve oral bioavailability, increase drug loading and enable smaller, simpler and more convenient dosage forms.

We are very happy to have Rosita on board and look forward to her contribution to our team and partner projects.
Welcome, Rosita!

Disruptive Pharma AB (publ) published this content on November 04, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 04, 2026 at 09:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]